Cancer Biotherapy and Radiopharmaceuticals

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

Aïcha Demidem, Tammy Lam, Steve Alas et al. · 1997 · 398 citations

Medicine, Immunology, Oncology +17

Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research

Carolyn J. Anderson, Riccardo Ferdani · 2009 · 372 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (anti <i>α</i> _v <i>β</i> ₃ ) Antibody in Patients with Metastatic Cancer

James Posey, M.B. Khazaeli, Alma Delgrosso et al. · 2001 · 190 citations

Medicine, Oncology, Pharmacology +16

Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with ¹⁷⁷ Lu DOTA-TATE and ¹⁷⁷ Lu DOTA-NOC

Christiane Wehrmann, Stefan Senftleben, Carolin Zachert et al. · 2007 · 175 citations

Medicine, Nuclear Medicine, Oncology +17

Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting

Marcel Janssen, Wim J.G. Oyen, Leon F.A.G. Massuger et al. · 2002 · 173 citations

Medicine, Oncology, Pharmacology +17